CAS: 1352608-82-2 - EW-7197
![N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-flu…](https://static.cymitquimica.com/products/IN/thumb/DA003AC8.jpg)
N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline
CAS:1352608-82-2
Formula:
C22H18FN7
Purity:
98%
Color and Shape:
Solid
Molecular weight:
399.4236
Ref: IN-DA003AC8
| 1g | To inquire | ||
| 1mg | 120.00 € | ||
| 100mg | 204.00 € | ||
| 250mg | 334.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Vactosertib
CAS:1352608-82-2
Vactosertib (EW-7197) is an oral TGFBR1/ALK5 inhibitor with potential cancer-fighting properties.
Formula:
C22H18FN7
Purity:
98.85% - 99.81%
Color and Shape:
Solid
Molecular weight:
399.42
Ref: TM-T6496
| 1g | 1,142.00 € | ||
| 2mg | 46.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 94.00 € | ||
| 25mg | 157.00 € | ||
| 50mg | 237.00 € | ||
| 100mg | 365.00 € | ||
| 200mg | 540.00 € | ||
| 500mg | 853.00 € | ||
| 1mL*10mM (DMSO) | 77.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
EW 7197
Controlled ProductCAS:1352608-82-2
Applications EW-7197 is a highly potent, selective, and orally bioavailable TGF-β I receptor ALK4/ALK5 inhibitor. …
Formula:
C22H18FN7
Color and Shape:
Neat
Molecular weight:
399.42
Ref: TR-E950000
| 25mg | 745.00 € |
Estimated delivery in United States, on Friday 14 Feb 2025
TEW 7197
CAS:1352608-82-2
TGF-? type I receptor antagonist; anti-cancer agent
Formula:
C22H18FN7
Purity:
Min. 95%
Molecular weight:
399.42 g/mol
Ref: 3D-BT168124
| 1g | To inquire | ||
| 100mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
